Ultragenyx Pharmaceutical Inc. (RARE): Weighted Average Diluted Shares
98.60M
Year ended 2025-12-31
+12.1%
3-year compound annual growth
+10.1%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 98.60M | +9.0% | 2026-02-18, From 2025-01-01 |
| 2024-12-31 | 90.50M | +23.1% | 2026-02-18, From 2024-01-01 |
| 2023-12-31 | 73.50M | +5.1% | 2026-02-18, From 2023-01-01 |
| 2022-12-31 | 69.91M | +3.1% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | 67.80M | +11.4% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | 60.85M | n/a | 2023-02-17, From 2020-01-01 |